Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



AbbVie Inc.

Symbol: ABBV     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
6.15%
Current Price
$66.81
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 07:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
7,828,000,000
7,828,000,000
1,694,000,000
6,134,000,000
3,124,000,000
3,010,000,000
2,456,000,000
-
-
n.a.
-
-
-
-
-
-
-
 
1,444,000,000

Financials 2018

Update: 2019-06-10 07:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
8,305,000,000
8,305,000,000
2,022,000,000
6,283,000,000
8,724,000,000
-2,441,000,000
-1,826,000,000
16,945,000,000
59,352,000,000
67,798,000,000
-8,446,000,000
7,289,000,000
5,308,000,000
8,061,000,000
40,310,000,000
-716,000,000
3,392,000,000
 
6,795,000,000

Q 3

2018-09-30
8,236,000,000
8,236,000,000
1,835,000,000
6,401,000,000
3,242,000,000
3,159,000,000
2,747,000,000
18,465,000,000
66,164,000,000
69,085,000,000
-2,921,000,000
8,015,000,000
4,021,000,000
8,785,000,000
40,508,000,000
4,477,000,000
4,524,000,000
 
1,323,000,000

Q 2

2018-06-30
8,278,000,000
8,278,000,000
1,934,000,000
6,344,000,000
3,582,000,000
2,762,000,000
1,983,000,000
13,845,000,000
61,641,000,000
65,016,000,000
-3,375,000,000
3,547,000,000
6,530,000,000
3,743,000,000
37,109,000,000
-5,425,000,000
2,866,000,000
 
1,322,000,000

Q 1

2018-03-31
7,934,000,000
7,934,000,000
1,927,000,000
6,007,000,000
3,104,000,000
2,903,000,000
2,783,000,000
20,444,000,000
69,342,000,000
65,789,000,000
3,553,000,000
9,007,000,000
6,381,000,000
9,474,000,000
37,287,000,000
-311,000,000
2,645,000,000
 
1,313,000,000

Financials 2017

Update: 2019-06-10 07:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
7,739,000,000
7,739,000,000
2,279,000,000
5,460,000,000
3,631,000,000
1,829,000,000
52,000,000
21,223,000,000
70,786,000,000
65,689,000,000
5,097,000,000
9,303,000,000
6,415,000,000
9,789,000,000
37,368,000,000
857,000,000
2,584,000,000
 
1,695,000,000